The Expense Ratio

The Expense Ratio is a crucial metric used in the context of employer-sponsored 401(k) retirement plans to assess the overall cost of managing investment funds within the plan. It represents the percentage of a participant's total invested assets that are deducted annually to cover the plan's operating expenses, administrative fees, management fees, and other costs associated with maintaining the investment options.

Explanation: In an employer 401(k) plan, employees have the option to allocate a portion of their pre-tax income into various investment funds. Each fund incurs expenses for portfolio management, record-keeping, legal compliance, and other services, which are collectively known as the expense ratio. A lower expense ratio is generally desirable as it translates to reduced costs, allowing participants to retain a higher proportion of their investment returns.

Examples:

  • Company A 401(k) Plan: The Company A 401(k) plan offers its employees a selection of mutual funds to invest in for their retirement savings. One of the available funds, the Large-Cap Equity Fund, has an expense ratio of 0.75%. For every $1,000 invested in this fund, $7.50 will be deducted annually to cover expenses associated with managing the fund.
  • Index Fund Option: In some 401(k) plans, participants may have access to low-cost index funds with expense ratios as low as 0.10%. For instance, the S&P 500 Index Fund has an expense ratio of 0.12%. This means that only $1.20 will be deducted yearly for every $1,000 invested in this fund, making it an attractive option for cost-conscious investors.
  • High-cost Fund Impact: Consider a participant who invests $50,000 in a high-cost bond fund with an expense ratio of 1.50%. In this case, $750 will be deducted annually from the participant's investment, significantly impacting the overall growth potential of their retirement savings over time. Choosing lower-cost alternatives can help enhance long-term returns in a 401(k) plan.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.